Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.
作者信息
Evans Paul E, Pardi Darrell S
机构信息
Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, Miles and Shirley Fiterman Center for Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
出版信息
MedGenMed. 2007 Mar 19;9(1):55.
Abstract
摘要
相似文献
1
2
[Possible role of mucosal lymphocyte homing in the pathogenesis of extraintestinal manifestations in inflammatory bowel diseases].
Orv Hetil. 2003 Jul 20;144(29):1441-6.
3
Extraintestinal Manifestations Associated with Inflammatory Bowel Disease.
Surg Clin North Am. 2015 Dec;95(6):1245-59, vii. doi: 10.1016/j.suc.2015.08.002.
4
Extraintestinal manifestations of inflammatory bowel disease.
Minerva Gastroenterol Dietol. 2005 Jun;51(2):147-63.
5
Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management.
Ann Med. 2010 Mar;42(2):97-114. doi: 10.3109/07853890903559724.
6
Inflammatory bowel disease: thinking outside of the intestines (Part 1).
J Miss State Med Assoc. 2008 Dec;49(12):359-64.
7
Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.
Minerva Gastroenterol Dietol. 2007 Sep;53(3):233-48.
8
Exercise and Inflammatory Bowel Disease: Insights into Etiopathogenesis and Modification of Clinical Course.
Gastroenterol Clin North Am. 2017 Dec;46(4):895-905. doi: 10.1016/j.gtc.2017.08.010.
9
Extraintestinal manifestations of inflammatory bowel diseases.
J Clin Gastroenterol. 2006 Jul;40(6):467-75. doi: 10.1097/00004836-200607000-00003.
10
Inflammatory bowel disease: complications and extraintestinal manifestations.
Drugs Today (Barc). 2009 Mar;45(3):227-41. doi: 10.1358/dot.2009.45.3.1343795.
引用本文的文献
1
Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre.
Prz Gastroenterol. 2024;16(4):397-407. doi: 10.5114/pg.2024.144988. Epub 2024 Nov 13.
2
Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies.
Biomedicines. 2024 Dec 16;12(12):2856. doi: 10.3390/biomedicines12122856.
3
Sweet or Not? Azathioprine-Induced Sweet Syndrome Mimicking Erythema Nodosum in a Patient With Inflammatory Bowel Disease.
ACG Case Rep J. 2024 Mar 29;11(4):e01321. doi: 10.14309/crj.0000000000001321. eCollection 2024 Apr.
4
Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era.
J Clin Med. 2022 Aug 4;11(15):4538. doi: 10.3390/jcm11154538.
5
Epidemiology of Ocular Manifestations in Autoimmune Disease.
Front Immunol. 2021 Nov 2;12:744396. doi: 10.3389/fimmu.2021.744396. eCollection 2021.
6
Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review.
Ther Adv Musculoskelet Dis. 2021 Mar 11;13:1759720X21996973. doi: 10.1177/1759720X21996973. eCollection 2021.
7
Dermatological Manifestations in Inflammatory Bowel Diseases.
J Clin Med. 2021 Jan 19;10(2):364. doi: 10.3390/jcm10020364.
8
Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.
Medicina (Kaunas). 2020 Aug 23;56(9):425. doi: 10.3390/medicina56090425.
9
Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
PLoS One. 2018 Jul 10;13(7):e0200363. doi: 10.1371/journal.pone.0200363. eCollection 2018.
10
Ophthalmic manifestations in patients with inflammatory bowel disease: A review.
World J Gastroenterol. 2017 Aug 28;23(32):5836-5848. doi: 10.3748/wjg.v23.i32.5836.
本文引用的文献
1
Treatment of chronic erythema nodosum with infliximab.
Clin Exp Dermatol. 2006 Nov;31(6):823-4. doi: 10.1111/j.1365-2230.2006.02221.x.
2
Extraintestinal manifestations and complications in inflammatory bowel diseases.
World J Gastroenterol. 2006 Aug 14;12(30):4819-31. doi: 10.3748/wjg.v12.i30.4819.
3
Prevention and treatment of osteoporosis in inflammatory bowel disease.
Inflamm Bowel Dis. 2006 Aug;12(8):797-813. doi: 10.1097/00054725-200608000-00016.
4
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Am J Gastroenterol. 2006 Jun;101(6):1274-82. doi: 10.1111/j.1572-0241.2006.00552.x.
5
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
Am J Gastroenterol. 2006 May;101(5):1012-23. doi: 10.1111/j.1572-0241.2006.00504.x.
6
Exacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?
World J Gastroenterol. 2006 Mar 14;12(10):1509-10. doi: 10.3748/wjg.v12.i10.1509.
7
Adalimumab reduces spinal symptoms in active ankylosing spondylitis: clinical and magnetic resonance imaging results of a fifty-two-week open-label trial.
Arthritis Rheum. 2006 Feb;54(2):678-81. doi: 10.1002/art.21563.
8
Important cutaneous manifestations of inflammatory bowel disease.
Postgrad Med J. 2005 Sep;81(959):580-5. doi: 10.1136/pgmj.2004.031633.
9
Management of extraintestinal manifestations and other complications of inflammatory bowel disease.
Curr Gastroenterol Rep. 2004 Dec;6(6):506-13. doi: 10.1007/s11894-004-0073-7.
10
Review article: skin complications associated with inflammatory bowel disease.
Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:50-3. doi: 10.1111/j.1365-2036.2004.02055.x.
Zotero 插件